GAMMA Investing’s Bristol-Myers Squibb BMY Stock Holding History

GAMMA Investing’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.02M	Sell	52,327 -1,556	-3%	-$89.3K	0.11%	144
2026 Q1	$3.27M	Buy	53,883 +11,854	+28%	+$691K	0.15%	102
2025 Q4	$2.27M	Buy	42,029 +3,814	+10%	+$183K	0.11%	151
2025 Q3	$1.72M	Sell	38,215 -2,293	-6%	-$107K	0.1%	178
2025 Q2	$1.88M	Buy	40,508 +823	+2%	+$40.4K	0.12%	153
2025 Q1	$2.42M	Buy	39,685 +6,267	+19%	+$365K	0.18%	94
2024 Q4	$1.89M	Buy	33,418 +6,032	+22%	+$337K	0.16%	108
2024 Q3	$1.42M	Buy	27,386 +10,410	+61%	+$488K	0.14%	139
2024 Q2	$705K	Sell	16,976 -448	-3%	-$20K	0.1%	190
2024 Q1	$945K	Buy	17,424 +4,348	+33%	+$221K	0.19%	89
2023 Q4	$639K	Buy	+13,076	New	+$686K	0.17%	94

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GAMMA Investing's BMY Position: Q2 2026 in Review

GAMMA Investing reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q2 2026, selling an estimated $89.3K and leaving 52,327 shares worth $3.02M. The position accounts for 0.11% of the portfolio, ranked #144.

GAMMA Investing first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.27M in Q1 2026. 775 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

GAMMA Investing held 52,327 shares of Bristol-Myers Squibb worth $3.02M as of Q2 2026.
GAMMA Investing sold 1,556 Bristol-Myers Squibb shares in Q2 2026, an estimated $89.3K.
Bristol-Myers Squibb made up 0.11% of GAMMA Investing's portfolio in Q2 2026, its #144 holding.
GAMMA Investing first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
GAMMA Investing's Bristol-Myers Squibb position peaked at $3.27M in Q1 2026.
775 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.